| Product Code: ETC7625744 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Despite a high Herfindahl-Hirschman Index (HHI) indicating concentrated market share, Ireland saw a decline in carcinoembryonic antigen import shipments in 2024. The top exporting countries, including the USA, UK, and Germany, continue to dominate the market. However, with a negative Compound Annual Growth Rate (CAGR) of -4.18% from 2020 to 2024 and a significant decline of -30.16% in growth rate from 2023 to 2024, the Irish market for carcinoembryonic antigen imports faced challenges and a downward trend in recent years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Carcinoembryonic Antigen Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Carcinoembryonic Antigen Market Revenues & Volume, 2022 & 2032F |
3.3 Ireland Carcinoembryonic Antigen Market - Industry Life Cycle |
3.4 Ireland Carcinoembryonic Antigen Market - Porter's Five Forces |
3.5 Ireland Carcinoembryonic Antigen Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Ireland Carcinoembryonic Antigen Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ireland |
4.2.2 Growing awareness about early cancer detection and screening |
4.2.3 Technological advancements in CEA testing methods |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for new CEA testing products |
4.3.2 Limited reimbursement policies for CEA testing in Ireland |
5 Ireland Carcinoembryonic Antigen Market Trends |
6 Ireland Carcinoembryonic Antigen Market, By Types |
6.1 Ireland Carcinoembryonic Antigen Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Ireland Carcinoembryonic Antigen Market Revenues & Volume, By Application, 2022 - 2032F |
6.1.3 Ireland Carcinoembryonic Antigen Market Revenues & Volume, By Colorectal Cancer, 2022 - 2032F |
6.1.4 Ireland Carcinoembryonic Antigen Market Revenues & Volume, By Pancreatic Cancer, 2022 - 2032F |
6.1.5 Ireland Carcinoembryonic Antigen Market Revenues & Volume, By Ovarian Cancer, 2022 - 2032F |
6.1.6 Ireland Carcinoembryonic Antigen Market Revenues & Volume, By Breast Cancer, 2022 - 2032F |
6.1.7 Ireland Carcinoembryonic Antigen Market Revenues & Volume, By Thyroid Cancer, 2022 - 2032F |
6.1.8 Ireland Carcinoembryonic Antigen Market Revenues & Volume, By Others, 2022 - 2032F |
7 Ireland Carcinoembryonic Antigen Market Import-Export Trade Statistics |
7.1 Ireland Carcinoembryonic Antigen Market Export to Major Countries |
7.2 Ireland Carcinoembryonic Antigen Market Imports from Major Countries |
8 Ireland Carcinoembryonic Antigen Market Key Performance Indicators |
8.1 Adoption rate of CEA testing in Ireland |
8.2 Number of healthcare facilities offering CEA testing services |
8.3 Investment in research and development for CEA testing technologies |
9 Ireland Carcinoembryonic Antigen Market - Opportunity Assessment |
9.1 Ireland Carcinoembryonic Antigen Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Ireland Carcinoembryonic Antigen Market - Competitive Landscape |
10.1 Ireland Carcinoembryonic Antigen Market Revenue Share, By Companies, 2025 |
10.2 Ireland Carcinoembryonic Antigen Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here